400 related articles for article (PubMed ID: 21671548)
1. Aspirin for the prevention of cardiovascular disease.
Lin KW
Am Fam Physician; 2011 Jun; 83(12):1469-70. PubMed ID: 21671548
[No Abstract] [Full Text] [Related]
2. Aspirin for the prevention of cardiovascular disease: recommendation statement.
Am Fam Physician; 2011 Jun; 83(12):1464-8. PubMed ID: 21671547
[No Abstract] [Full Text] [Related]
3. Benefits versus risks of aspirin in cardioprotection: dangers of heart attack after discontinuation.
Wynn RL
Gen Dent; 2012; 60(4):255-8. PubMed ID: 22782034
[No Abstract] [Full Text] [Related]
4. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
Ridker PM; Cook NR; Lee IM; Gordon D; Gaziano JM; Manson JE; Hennekens CH; Buring JE
N Engl J Med; 2005 Mar; 352(13):1293-304. PubMed ID: 15753114
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aspirin in the long-term management of atherothrombosis.
Patrono C
Haematologica; 2002 Jan; 87(1):6-8. PubMed ID: 11801459
[No Abstract] [Full Text] [Related]
6. Aspirin and gastrointestinal toxicity.
Törüner M
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():27-30. PubMed ID: 18160364
[TBL] [Abstract][Full Text] [Related]
7. Appropriate aspirin use for primary prevention of cardiovascular disease.
Miser WF
Am Fam Physician; 2011 Jun; 83(12):1380-6. PubMed ID: 21671538
[No Abstract] [Full Text] [Related]
8. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
Maywald U; Schindler C
Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
[No Abstract] [Full Text] [Related]
9. The case against routine aspirin use for primary prevention in low-risk adults.
Bailey AL; Smyth SS; Campbell CL
Am Fam Physician; 2011 Jun; 83(12):1387-90. PubMed ID: 21671539
[No Abstract] [Full Text] [Related]
10. No one-size-fits-all for aspirin and elders.
Harv Heart Lett; 2005 Sep; 16(1):7. PubMed ID: 16211726
[No Abstract] [Full Text] [Related]
11. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
Hennekens CH; Schneider WR
Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
[TBL] [Abstract][Full Text] [Related]
12. Enteric coated aspirin.
Grossman CM
Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216
[No Abstract] [Full Text] [Related]
13. The prevalence of co-administration of clopidogrel and proton pump inhibitors.
Shrestha K; Hughes JD; Lee YP; Parsons R
Qual Prim Care; 2011; 19(1):35-42. PubMed ID: 21703110
[TBL] [Abstract][Full Text] [Related]
14. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
Temizhan A
Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
[TBL] [Abstract][Full Text] [Related]
15. Should patients stop taking aspirin for primary prevention?
Depta JP; Bhatt DL
Cleve Clin J Med; 2015 Feb; 82(2):91-6. PubMed ID: 25897597
[No Abstract] [Full Text] [Related]
16. The lady aspirin for cardiovascular disease.
Verheugt FW; Smith SC
Lancet; 2005 Oct; 366(9492):1148-50. PubMed ID: 16198753
[No Abstract] [Full Text] [Related]
17. A long-term risk-benefit analysis of low-dose aspirin in primary prevention.
Wu IC; Hsieh HM; Yu FJ; Wu MC; Wu TS; Wu MT
Eur J Clin Invest; 2016 Feb; 46(2):130-40. PubMed ID: 26640116
[TBL] [Abstract][Full Text] [Related]
18. Ethical considerations in relation to aspirin prophylaxis.
Morgan G
Qual Prim Care; 2008; 16(6):433-40. PubMed ID: 19094419
[TBL] [Abstract][Full Text] [Related]
19. Application of U.S. guidelines in other countries: aspirin for the primary prevention of cardiovascular events in Japan.
Morimoto T; Fukui T; Lee TH; Matsui K
Am J Med; 2004 Oct; 117(7):459-68. PubMed ID: 15464702
[TBL] [Abstract][Full Text] [Related]
20. Antiplatelet drugs in cardiovascular prevention: coronary events and stroke: primary prevention.
Prescrire Int; 2000 Jun; 9(47):89-90. PubMed ID: 11010752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
